A phase II study of continuous daily administration of sunitinib in patients with cytokine-refractory metastatic renal cell carcinoma (mRCC) - final results
Journal title abbreviation:
EJC Suppl
Year:
2007
Journal volume:
5
Journal issue:
4
Pages contribution:
299-300
Language:
eng
Print-ISSN:
1359-6349
TUM Institution:
III. Medizinische Klinik und Poliklinik (Hämatologie / Onkologie)